Cooperative Research Centres


 

mjenkins

Misty Jenkins

As a child, Misty Jenkins, a young Gunditjmara woman from western Victoria, was fascinated by the way the human body works and how it manages to protect itself from infectious diseases yet succumbs to viruses. She later became interested in a career in scientific research after discovering that Aboriginal Australians have some of the poorest health conditions in the world and are susceptible to so many infectious diseases.

Misty successfully pursued her career goal and is currently completing a PhD with Nobel Laureate Professor Peter Doherty and Dr Stephen Turner at the University of Melbourne. She has been researching T cells, which are white blood cells responsible for fighting infection. Her research will help in the design of better vaccines, targeting pandemic influenza or HIV.

'Killer T cells are able to recognise when our body is infected and are able to specifically destroy virus-infected cells. They do this by acting like a soldier: the killer T cells throw grenades at their target. I have been examining what sort of grenades they throw, and how many. We have shown that the cells need to have divided a few times before they switch on their killing molecules, and they produce many different types of ‘grenades’. With this sort of knowledge, we can design T cell vaccines that promote the right sort of immunity, which will be potent and specific against the invading virus.'

Earlier in 2006 Misty applied for funds from the CRC for Aboriginal Health International Program, funded by the Office of Aboriginal and Torres Strait Islander Health, after being invited to present her research during a plenary session of the Keystone Symposia conference, Viral Immunity: From Basic Mechanisms to Vaccines.

Her research presentation generated a lot of excitement and interest as it discusses some of the mechanisms that contribute to the T cell killing function.

'This knowledge enables us to understand how killer T cells are generated and will aid the design of T cell mediated vaccines. The feedback I received was that this study has provided valuable insights into T cell immunity. I feel that I made a valuable contribution towards the conference and also I found the experience extremely rewarding for my career. I was able to interact with the world’s leading immunologists and talk about my research with them. This experience is essential for a young scientist to increase network opportunities and receive feedback about my research. I was offered multiple academic appointments at the conference, which means I am currently deciding where I will be employed next year. Attending the conference gave me enormous opportunities to further promote myself, my research and the CRC for Aboriginal Health, which was appropriately acknowledged during the plenary session.

'I would like to thank the CRC for Aboriginal Health very much for supporting my opportunity to attend the Keystone Symposia through your Indigenous International Program. It was a valuable opportunity and one which has helped shaped my future career.'

From CRCAH Annual Report 2005/2006

Misty is now pursuing post-doctoral work at Oxford University in England, following the completion of her PhD.

 Back to Profiles

All Content © CRC for Aboriginal Health 2006